Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

May 5, 2021

Primary Completion Date

July 19, 2022

Study Completion Date

July 19, 2022

Conditions
Hemophilia AHemophilia B
Interventions
DIAGNOSTIC_TEST

Hemophilia Joint Health Score (HJHS)

Joint examination with Hemophilia Joint Health Score (HJHS)

Trial Locations (16)

Unknown

Swedish Orphan Biovitrum Clinical site, Paris

Swedish Orphan Biovitrum Clinical site, Paris

Swedish Orphan Biovitrum Clinical site, Besançon

Swedish Orphan Biovitrum Clinical site, Bordeaux

Swedish Orphan Biovitrum Clinical site, Brest

Swedish Orphan Biovitrum Clinical site, Caen

Swedish Orphan Biovitrum Clinical site, Clermont-Ferrand

Swedish Orphan Biovitrum Clinical site, Dijon

Swedish Orphan Biovitrum Clinical site, Lyon

Swedish Orphan Biovitrum Clinical site, Marseille

Swedish Orphan Biovitrum Clinical site, Nancy

Swedish Orphan Biovitrum Clinical site, Nantes

Swedish Orphan Biovitrum Clinical site, Rouen

Swedish Orphan Biovitrum Clinical site, Saint-Etienne

Swedish Orphan Biovitrum Clinical site, Strasbourg

Swedish Orphan Biovitrum Clinical site, Toulouse

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Kantar Health

INDUSTRY

collaborator

Cerner Enviza (former Kantar Health)

UNKNOWN

lead

Swedish Orphan Biovitrum

INDUSTRY